• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Early response evaluation in AML using mass cytometry.

作者信息

Gjertsen Bjørn T, Tislevoll Benedicte S, Fagerholt Oda H E, Hellesøy Monica

机构信息

Center for Cancer Biomarkers CCBIO, Department of Clinical Science, Precision Oncology Research Group, University of Bergen, Norway.

Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.

出版信息

Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000215. eCollection 2019 Jun.

DOI:10.1097/HS9.0000000000000215
PMID:35309799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8925711/
Abstract
摘要

相似文献

1
Early response evaluation in AML using mass cytometry.利用质谱流式细胞术对急性髓系白血病进行早期反应评估。
Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000215. eCollection 2019 Jun.
2
Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.单细胞质谱流式细胞术揭示了FLT3-ITD突变的急性髓系白血病干/祖细胞中的细胞内存活/增殖信号。
Cytometry A. 2015 Apr;87(4):346-56. doi: 10.1002/cyto.a.22628. Epub 2015 Jan 16.
3
Multiplexed single-cell mass cytometry reveals distinct inhibitory effects on intracellular phosphoproteins by midostaurin in combination with chemotherapy in AML cells.多重单细胞质谱流式细胞术揭示了米哚妥林联合化疗对急性髓系白血病（AML）细胞内磷酸化蛋白具有不同的抑制作用。
Exp Hematol Oncol. 2021 Feb 2;10(1):7. doi: 10.1186/s40164-021-00201-w.
4
Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category.通过流式细胞术评估初发急性髓系白血病中的髓系和单核细胞发育异常有助于定义伴有髓系发育异常相关改变的急性髓系白血病类别。
J Clin Pathol. 2017 Feb;70(2):109-115. doi: 10.1136/jclinpath-2016-203863. Epub 2016 Jul 7.
5
Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy.急性髓系白血病的质谱流式细胞术功能分析确定了与已知治疗反应相关的细胞周期和免疫表型特征。
Cancer Discov. 2015 Sep;5(9):988-1003. doi: 10.1158/2159-8290.CD-15-0298. Epub 2015 Jun 19.
6
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol.根据AIEOP-AML 2002/01研究方案治疗的急性髓系白血病患儿微小残留病的流式细胞术评估的预后意义
Br J Haematol. 2017 Apr;177(1):116-126. doi: 10.1111/bjh.14523. Epub 2017 Feb 27.
7
[Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].[多参数流式细胞术在慢性粒单核细胞白血病、骨髓增生异常综合征及急性单核细胞白血病免疫表型鉴别中的意义及应用价值]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):857-62.
8
High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy.急性髓系白血病的高维分析揭示诱导治疗期间持续细胞的表型变化。
PLoS One. 2016 Apr 13;11(4):e0153207. doi: 10.1371/journal.pone.0153207. eCollection 2016.
9
Single-Cell Mass Cytometry of Acute Myeloid Leukemia and Leukemia Stem/Progenitor Cells.急性髓系白血病及白血病干/祖细胞的单细胞质谱流式细胞术
Methods Mol Biol. 2017;1633:75-86. doi: 10.1007/978-1-4939-7142-8_5.
10
Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia.儿童急性髓系白血病治疗期间残留病的临床意义。
Br J Haematol. 2003 Oct;123(2):243-52. doi: 10.1046/j.1365-2141.2003.04610.x.

引用本文的文献

1
Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts.急性髓细胞白血病中的微小残留病：旧概念与新概念。
Int J Mol Sci. 2024 Feb 10;25(4):2150. doi: 10.3390/ijms25042150.
2
Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going.流式细胞术检测急性髓系白血病微小残留病：现状与展望综述
J Clin Med. 2020 Jun 3;9(6):1714. doi: 10.3390/jcm9061714.
3
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial.

本文引用的文献

1
Identification of functionally primitive and immunophenotypically distinct subpopulations in secondary acute myeloid leukemia by mass cytometry.通过液质联用技术鉴定继发性急性髓细胞白血病中功能原始和免疫表型不同的亚群。
Cytometry B Clin Cytom. 2019 Jan;96(1):46-56. doi: 10.1002/cyto.b.21743. Epub 2018 Nov 13.
2
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.CSF1R 抑制剂通过阻断支持细胞的旁分泌信号在急性髓细胞白血病中发挥抗肿瘤活性。
Blood. 2019 Feb 7;133(6):588-599. doi: 10.1182/blood-2018-03-838946. Epub 2018 Nov 13.
3
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
急性髓系白血病中白血病相关免疫表型的早期外周清除：一项随机试验的集中分析。
Blood Adv. 2020 Jan 28;4(2):301-311. doi: 10.1182/bloodadvances.2019000406.
急性髓系白血病中的微小残留病：来自欧洲白血病网微小残留病工作组的共识文件。
Blood. 2018 Mar 22;131(12):1275-1291. doi: 10.1182/blood-2017-09-801498. Epub 2018 Jan 12.
4
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.应用质谱流式细胞术对新诊断的慢性期慢性髓性白血病患者进行单细胞免疫分析，这些患者接受了尼罗替尼的治疗。
Haematologica. 2017 Aug;102(8):1361-1367. doi: 10.3324/haematol.2017.167080. Epub 2017 May 18.
5
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
6
High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy.急性髓系白血病的高维分析揭示诱导治疗期间持续细胞的表型变化。
PLoS One. 2016 Apr 13;11(4):e0153207. doi: 10.1371/journal.pone.0153207. eCollection 2016.
7
Highly multiplexed simultaneous detection of RNAs and proteins in single cells.单细胞中RNA和蛋白质的高度多重同步检测。
Nat Methods. 2016 Mar;13(3):269-75. doi: 10.1038/nmeth.3742. Epub 2016 Jan 25.
8
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.“3+7”诱导方案治疗急性髓系白血病第 5 天与第 14 天早期骨髓评估的前瞻性比较。
Am J Hematol. 2015 Dec;90(12):1159-64. doi: 10.1002/ajh.24207. Epub 2015 Nov 17.
9
Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia.外周血微小残留病可能取代骨髓微小残留病成为急性髓系白血病复发的免疫表型生物标志物。
Leukemia. 2016 Mar;30(3):708-15. doi: 10.1038/leu.2015.255. Epub 2015 Sep 16.
10
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.急性髓系白血病的数据驱动表型剖析揭示了与预后相关的祖细胞样细胞。
Cell. 2015 Jul 2;162(1):184-97. doi: 10.1016/j.cell.2015.05.047. Epub 2015 Jun 18.